FDA Inspection 1322424 — Creative Testing Solutions

Creative Testing Solutions — FEI 1000140241

The FDA completed an inspection of Creative Testing Solutions on June 4, 2026 in Charlotte, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 4, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Charlotte, NC (United States)